High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome

Weitere Versionen anzeigen (2)

High hyperdiploidy (HeH, 51-65 chromosomes) is an established genetic subtype of acute lymphoblastic leukaemia (ALL). The clinical and cytogenetic features as well as outcome of HeH among adolescents and adults have not been thoroughly investigated. Among 1232 B-cell precursor ALL patients (15-65 ye...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Chilton, L, Buck, G, Harrison, C, Ketterling, R, Rowe, J, Tallman, MS, Goldstone, A, Fielding, A, Moorman, A
Format:	Journal article
Sprache:	English
Veröffentlicht:	Nature Publishing Group 2014

Ähnliche Einträge

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.
von: Chilton, L, et al.
Veröffentlicht: (2014)

High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome
von: Chilton, L, et al.
Veröffentlicht: (2014)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
von: Moorman, A, et al.
Veröffentlicht: (2005)

Is hyperdiploidy a favorable cytogenetics in adults with B‐lymphoblastic leukemia?
von: Zhining Chen, et al.
Veröffentlicht: (2019-08-01)

Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia
von: Eleanor L. Woodward, et al.
Veröffentlicht: (2023-03-01)

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
von: Sive, J, et al.
Veröffentlicht: (2012)

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics
von: Moorman, A, et al.
Veröffentlicht: (2012)

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
von: Marks, D, et al.
Veröffentlicht: (2009)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
von: Moorman, A, et al.
Veröffentlicht: (2007)

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MIRD) clearance in childhood lymphoblastic leukaemia (ALL)
von: Moorman, A, et al.
Veröffentlicht: (2008)

Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study.
von: Rai, L, et al.
Veröffentlicht: (2010)

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.
von: Moor-Man, A, et al.
Veröffentlicht: (2009)

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
von: Moorman, A, et al.
Veröffentlicht: (2007)

High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis.
von: Patel, B, et al.
Veröffentlicht: (2008)

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis
von: Moorman, A, et al.
Veröffentlicht: (2005)

Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
von: Fielding, A, et al.
Veröffentlicht: (2010)

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
von: Fielding, A, et al.
Veröffentlicht: (2010)

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
von: Fielding, A, et al.
Veröffentlicht: (2010)

Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993).
von: Goldstone, A, et al.
Veröffentlicht: (1999)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
von: Moorman, A, et al.
Veröffentlicht: (2007)

Adult patients with acute lymphoblastic leukaemia (ALL) who relapse have a dismal outlook: Results from MRC UKALL XII/ECOG 2993 trial.
von: Chopra, R, et al.
Veröffentlicht: (2003)

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups
von: Lrrzow, MR, et al.
Veröffentlicht: (2010)

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
von: Ramanujachar, R, et al.
Veröffentlicht: (2007)

Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph plus) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993).
von: Goldstone, A, et al.
Veröffentlicht: (2001)

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.
von: Chessells, J, et al.
Veröffentlicht: (2002)

Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia
von: Chilton, L, et al.
Veröffentlicht: (2017)

COPY NUMBER ALTERATIONS ASSOCIATED WITH HYPERDIPLOIDY IN CHILDHOOD WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
von: RS Torres, et al.
Veröffentlicht: (2024-10-01)

ASSOCIATION OF HYPERDIPLOIDY WITH REMISSION STATUS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AFTER INDUCTION THERAPY
von: Saqib Hussain Korejo, et al.
Veröffentlicht: (2019-06-01)

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
von: Sive, J, et al.
Veröffentlicht: (2010)

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
von: Sive, J, et al.
Veröffentlicht: (2010)

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial
von: Sive, J, et al.
Veröffentlicht: (2010)

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
von: Fielding, A, et al.
Veröffentlicht: (2007)

The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study
von: Patel, B, et al.
Veröffentlicht: (2005)

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
von: Rowe, J, et al.
Veröffentlicht: (2008)

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups
von: Lrrzow, MR, et al.
Veröffentlicht: (2010)

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups
von: Lrrzow, MR, et al.
Veröffentlicht: (2010)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
von: Moorman, A, et al.
Veröffentlicht: (2007)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.
von: Harrison, C, et al.
Veröffentlicht: (2004)

Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features
von: Claire J. Schwab, et al.
Veröffentlicht: (2013-07-01)

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
von: Moorman, A, et al.
Veröffentlicht: (2010)